• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

British Columbia’s Supreme Court approves Canopy Growth, Acreage arrangement

Share:

June 24, 2019

Acreage Holdings obtains a final order from the Supreme Court of British Columbia approving the previously announced agreement with Canopy Growth.

Under the arrangement, Acreage will amend its articles to provide Canopy Growth with the option to acquire all shares of Acreage and a requirement to do so once federal U.S. laws permit the general cultivation, distribution, and possession of marijuana or to remove the regulation of such activities from federal U.S. law.

Canopy Growth is permitted to waive the triggering event and intends to do so as soon as policies of the New York Stock Exchange and/or the Toronto Stock Exchange permit completion of the acquisition.

Acreage and Canopy Growth expect to implement the arrangement on or about June 27, 2019.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Holders of Acreage shares and certain securities convertible into Class A subordinate voting shares will be entitled to receive their pro rata portion of US$300M, the option premium, being paid by Canopy Growth as consideration for granting the Canopy Growth Call Option.

Each holder of Acreage shares will get about US$2.63 per suburdinate voting share pursuant to the option premium.

Date: June 24, 2019

Source: Seeking Alpha

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Cowen Healthcare Raises $556M Fund to Invest in Life Sciences CompaniesCowen Healthcare Raises $556M Fund to Invest in Life Sciences Companies
  • Teladoc Builds Out Mental Healthcare Services with MyStrength CompleteTeladoc Builds Out Mental Healthcare Services with MyStrength Complete
  • PathAI Lands $60M to Accelerate AI-Powered Pathology PlatformPathAI Lands $60M to Accelerate AI-Powered Pathology Platform
  • Sanofi Pushes Further Into Immuno-Oncology with $2.5 Billion Synthorx TakeoverSanofi Pushes Further Into Immuno-Oncology with $2.5 Billion Synthorx Takeover
  • InsightRX, Premier Partner to Bring Precision Antibiotic Dosing to 4,000 HospitalsInsightRX, Premier Partner to Bring Precision Antibiotic Dosing to 4,000 Hospitals
  • PainChek Pain Recognition app Granted US Patent for Pain Assessment InventionPainChek Pain Recognition app Granted US Patent for Pain Assessment Invention
  • France Uses Medication Shield Technology as Part of Covid-19 Vaccination CampaignFrance Uses Medication Shield Technology as Part of Covid-19 Vaccination Campaign
  • Core One Labs Signs Letter of Intent to Acquire Vocan BiotechnologiesCore One Labs Signs Letter of Intent to Acquire Vocan Biotechnologies

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications